Ningbo Tianyi Medical Appliance Co., Ltd. is a China-based medical device manufacturer primarily engaged in the research, development, production, and distribution of disposable medical consumables and blood purification devices. The company operates across three core business segments: Extracorporeal Blood Purification Consumables, Enteral Feeding and Infusion Sets, and General Medical Consumables. Its primary product offerings include extracorporeal blood circuit tubing sets for hemodialysis and continuous renal replacement therapy (CRRT); arteriovenous fistula puncture needles and hemodialysis catheter connection accessories; hollow fiber dialyzers and hemoperfusion cartridges; enteral nutrition administration sets, including feeding bags, nasogastric feeding tubes, and enteral infusion pumps; precision filtration infusion sets, light-resistant IV administration sets, and blood transfusion apparatus; disposable intravenous indwelling cannula needles, extension tubes, and heparin caps; and general healthcare consumables, such as surgical suction tubes, negative pressure drainage containers, and medical dressing kits. The company provides both proprietary branded medical devices and customized original equipment manufacturing (OEM) and original design manufacturing (ODM) solutions for domestic and international healthcare enterprises. Founded in 1998 and headquartered in Ningbo, Zhejiang Province, China, the company supplies public hospitals, specialized dialysis centers, clinical healthcare networks, and medical distributors across mainland China, while exporting products to overseas markets across Europe, the Americas, the Middle East, and the Asia-Pacific region. In recent developments, Ningbo Tianyi Medical Appliance Co., Ltd. has accelerated capacity expansion through the construction and upgrading of automated cleanroom production facilities dedicated to high-flux dialyzers and advanced renal care consumables; advanced the global compliance of its product lines under the European Union Medical Device Regulation (MDR) to expand direct export channels; widened its product portfolio into smart infusion management accessories and specialized intensive-care drainage systems; and adapted its commercial strategy to optimize bidding participation within China's national and regional volume-based procurement (VBP) programs, enhancing hospital access and domestic supply chain integration.